Even if we don't get EUA, we will likely get at least 1 of the other countries that we are applying for. The UK and the EU rely heavier on NEWS2 for assessment, which we crushed. The point is to get the drug out there, as it works, so even if approved in other countries the word of successful treatments will travel quickly. That will put the FDA under a lot of pressure if an American company with an American drug is saving non-Americans. Additionally, why wouldn't we get uplisting? We meet the criteria.